This webcast originally aired as a live webinar sponsored
by AACC on December 10, 2013. During this program, Dr. Alexandra Valsamakis,
Director, Clinical Virology and Molecular Microbiology at The Johns Hopkins
Hospital in Baltimore, describes how new CDC hepatitis C virus (HCV) screening
recommendations and new, highly effective antiviral therapies are changing how
clinicians test and treat people with, or suspected of having HCV.